Breaking News
Domino's Pizza   BlackRock   Netflix   GE Aerospace   TSMC   Bank of America    Morgan Stanley     Goldman Sachs Group  
  • ALL
    • Breaking News
    Oct 12, 2023
    • Walgreens Boots Alliance increased 0.8% to $22.89 after the retail pharmacy chain reported mixed quarterly results and forecasted weak annual earnings growth outlook. 

      Revenue in the fiscal fourth quarter  ending in August increased to $35.4 billion from $32.4 billion and net loss shrank from $180 million from $415 million and diluted loss per share fell to 21 cents from 48 cents a year ago. 

      Fiscal 2023 sales increased 4.8% to $139.1 billion from $132.7 billion and net income swung to a loss of $3.1 billion from $4.3 billion a year ago. 

      Earnings in the year were impacted by the sharp decline in Covid-19 testing and vaccine volumes.   

      The pharmacy retail chain guided fiscal 2024 sales in the range between $141 billion and $145 billion and adjusted earnings per share between $3.20 and $3.50. 
      • Domino's Pizza Inc declined 3.4%  to $346.50 after the food company reported weaker-than-expected earnings and sales at U.S. comparable locations declined 0.6%. 

        Total revenue in the quarter ending on August 10 eased to $1.02 billion from $1.06 billion and net income soared to $147.7 million from $100.5 million and diluted earnings per share surged to $4.18 from $2.79 a year ago. 

        Excluding the impact of the  closure of the Russia market, the global net store count in the third quarter was 135 stores, comprising 27 net U.S. and 108 net international store openings.

        The pizza delivery company forecasted its 2023 global net store growth "to trend at or slightly below the low-end" of its 5% to 7% two- to three-year outlook. 

        Additionally, the company estimated its 2023 global retail sales growth, excluding foreign currency impact, "to trend modestly below the midpoint" of its 4% to 8% two -to three-year outlook.
        • Oct 11, 2023
        • Sherwin-Williams Company was unchanged at $252.0 and the company said President Heidi G Petz will assume additional role of chief executive from the  start of 2024.
          • Humana Inc declined 1.2% to $494.0 after the health insurance company said chief executive Bruce Broussard will step down in the second-half of 2024. 

            The company named health care industry veteran Jim Rechtin as President and Chief Operating Officer effective January 8, 2024, as part of a long-planned CEO transition and Rechtin will assume chief executive's role after Broussard steps down.  
            • Novo Nordisk AS jumped 3.4% to  $96.34 after the Danish company said it will stop kidney trials earlier because of promising results.

              The company's drug therapy Ozempic uses active ingredient semaglutide, which the company also uses in the making of its weight-loss drug Wegovy. 

              After the Novo Nordisk's news,  Davita Inc plunged 18% to $54.58 and Fresenius Medical Care dropped 16.7% to $17.45. 
              • Pioneer Natural Resources Company jumped 1.9% to $241.79 after the company agreed to be acquired by Exxon Mobil in an all-stock merger for $253 a share or $60 billion. 
                • The producer price index rose 0.5% in September from the previous month, and slower than 0.7% in August, the U.S. Bureau of Labor Statistics reported Wednesday. 

                  However, wholesale inflation on an annual basis accelerated to 2.2% in the month from 2.0% in the previous month and advanced for the third month in a row. 
                  • Oct 10, 2023
                  • PepsiCo gained 1.5% to $163.81 after the beverage and food company reported its quarterly results and the company also lifted its full-year outlook. 

                    Net revenue in the third quarter ending in September increased 6.7% to $23.45 billion from $21.97 billion and net income attributable to shareholders increased to $3.09 billion from $2.70 billion and diluted earnings per share advanced to $2.24 from $1.95 a year ago. 

                    In North America, beverage sales increased 8%, Frito Lay sales rose 7% and Quaker Foods advanced 5%. 

                    The company slightly revised higher its 2023 earnings outlook and estimated core earnings per share of $7.54 compared to its previous estimate of $7.47 and compared to $6.79 a year ago.   
                    • Bristol-Myers Squibb Co edged up 0.1% to $56.68 after the company agreed to acquire San Diego-based Mirati Therapeutics for $58 a share or $4.8 billion on Sunday evening. 

                      The company also agreed to as much as additional $1 billion  in milestone payments. 

                      With the purchase of Mirati, Bristol-Myers expanded its cancer treatment portfolio after Mirati's non-small cell lung cancer drug Krazati was approved by the U.S. FDA.  
                      • Palantir Technologies Inc increased 2.7% to $18.09 on news that the U.S. Army assigned a $250 million contract to test and develop artificial Intelligence tools.